Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient preference study of sustained-release versus immediate-release paracetamol for knee osteoarthritis
ACTRN12607000565448Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acetaminophen in knee osteoarthritis (OA), sponsored by GSK. Primary endpoint: Patient preference for a particular treatment in the management of osteoarthritis pain. Started Nov 2007; status: completed.
02
Drugs
acetaminophen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12607000565448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000565448.